About: BI 811283

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

BI 811283 is a small molecule inhibitor of the Aurora B kinase protein being developed by Boehringer Ingelheim for use as an anti-cancer agent. BI 811283 is currently in the early stages of clinical development and is undergoing first in human trials in patients with solid tumors and acute myeloid leukemia.

Property	Value
dbo:abstract	BI 811283 is a small molecule inhibitor of the Aurora B kinase protein being developed by Boehringer Ingelheim for use as an anti-cancer agent. BI 811283 is currently in the early stages of clinical development and is undergoing first in human trials in patients with solid tumors and acute myeloid leukemia. (en)
dbo:casNumber	1802182-21-3
dbo:thumbnail	wiki-commons:Special:FilePath/BI_811283.svg?width=300
dbo:wikiPageID	31694035 (xsd:integer)
dbo:wikiPageLength	11417 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1050288924 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cancer dbr:Pre-clinical_development dbr:Enzyme_inhibitor dbr:Non-small-cell_lung_carcinoma dbr:Boehringer_Ingelheim dbr:Brain_tumor dbr:In_vitro dbr:In_vivo dbr:Colorectal_cancer dbr:Small_molecule dbr:Phase_1_clinical_trial dbr:Phase_2_study dbc:Experimental_cancer_drugs dbr:Lung_cancer dbr:Clinical_trial dbr:Clinical_development dbr:Pancreatic_cancer dbr:Aurora_B_kinase dbr:Head_and_neck_cancer dbr:Acute_myeloid_leukemia dbr:Adenosine_triphosphate dbr:Fever dbr:Aneuploidy dbr:Cell_death dbr:Cell_division dbr:Chromosome dbr:Protein dbr:Adverse_effect dbr:Polyploid dbr:Infection dbr:Side_effect dbr:White_blood_cell dbr:Neutropenia dbr:Senescence dbr:Ovarian_cancer dbr:Leucopenia dbr:Blood_stream dbr:Food_&_Drug_Administration dbr:Solid_tumor dbr:Anti-cancer_agent dbr:Anti-cancer_drug
dbp:c	28 (xsd:integer)
dbp:casNumber	1802182 (xsd:integer)
dbp:f	3 (xsd:integer)
dbp:h	38 (xsd:integer)
dbp:image	BI 811283 ball-and-stick 5K3Y.png (en)
dbp:iupacName	4 (xsd:integer)
dbp:legalStatus	Investigational (en)
dbp:n	7 (xsd:integer)
dbp:o	2 (xsd:integer)
dbp:smiles	FCC=CN=C1NC3=CC=CC=C3 (en)
dbp:stdinchi	1 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Infobox_drug dbt:Reflist
dcterms:subject	dbc:Experimental_cancer_drugs
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug
rdfs:comment	BI 811283 is a small molecule inhibitor of the Aurora B kinase protein being developed by Boehringer Ingelheim for use as an anti-cancer agent. BI 811283 is currently in the early stages of clinical development and is undergoing first in human trials in patients with solid tumors and acute myeloid leukemia. (en)
rdfs:label	BI 811283 (en)
owl:sameAs	wikidata:BI 811283 https://global.dbpedia.org/id/4Um2g
prov:wasDerivedFrom	wikipedia-en:BI_811283?oldid=1050288924&ns=0
foaf:depiction	wiki-commons:Special:FilePath/BI_811283.svg wiki-commons:Special:FilePath/BI_811283_ball-and-stick_5K3Y.png
foaf:isPrimaryTopicOf	wikipedia-en:BI_811283
is dbo:wikiPageRedirects of	dbr:BI811283
is dbo:wikiPageWikiLink of	dbr:BI811283
is foaf:primaryTopic of	wikipedia-en:BI_811283